Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells by unknown
DEFECTIVE LYMPHOPOIESIS IN BONE MARROW OF
MOTHEATEN (me/me) AND VIABLE MOTHEATEN (me"/me")
MUTANT MICE
I. Analysis of Development of Prothymocytes, Early B Lineage Cells,
and Terminal Deoxynucleotidyl Transferase-positive Cells
BY DALE L. GREINER,* IRVING GOLDSCHNEIDER,*
KRISTIN L. KOMSCHLIES,* EUGENE S. MEDLOCK,*
FREDERICKJ. BOLLUM,§ AND LEONARD SCHULTZ$
From *The Department ofPathology, School ofMedicine, University of Connecticut Health
Center, Farmington, Connecticut 06032; *The fackson Laboratory, Bar Harbor, Maine 04609;
and 5the Department ofBiochemistry, UniformedServices University oftheHealth Sciences,
Bethesda, Maryland 20814
Mice homozygous for the autosomal recessive single gene allelic mutations,
motheaten (me/me) and viable motheaten (me"/me"), are unique among mutant
mice in that they develop autoimmune syndromes in association with severe
combined immunodeficiency disorders (SCID) (see 1 for review). Homozygous
me/me and me"/me" mice have mean lifespans of 22 and 61 d, respectively, and
can be recognized as early as 1-3 d by the development of severe dermatitis and
patchy alopecia (2, 3). Autoimmune abnormalities include hypergammaglobuli-
nemia, the production of multiple autoantibodies, and the development of
immune complex glomerulonephritis (3-7). In addition, the dermatitis that
characterizes these mutants and the hemorrhagic macrophagic pneumonitis that
is the usual cause of death, are suspected to have an autoimmune basis (1).
Despite the evidence (3-8) for polyclonal B cell activation in me/me and
me"/me" mice, these animals are severely immunodeficient. Thus, the number of
peripheral B lymphocytes is decreased by approximately two-thirds in these
mutants, and although normal numbers ofperipheral T cells are present, thymic
involution commences by 4 wk of age, antigen-specific cytotoxic T cell activity
and mitogen-induced blastogenesis is markedly reduced, and antibody responses
to thymic-dependent (and thymic-independent) antigens are undetectable (1-8).
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The above autoimmune and immunodeficiency disorders in me/me and me"/me°
mice have been postulated to result, at least in part, from immunoregulatory
imbalances related to the excessive production of a B cell maturation factor (5,
9, 10) and from the hyperactivity of a population of suppressor macrophages (6).
Motheaten (me/me) mice have been reported (11) to have markedly reduced
numbers of terminal deoxynucleotidyl transferase (TdT)'-positive cells in their
bone marrow and thymus. This observation is of particular interest in that TdT
appears to be selectively expressed by primitive members of both the T and B
cell lineages (12-16), and TdT itself has been postulated to be involved in the
diversification of antigen receptors and/or in the programmed death of imma-
ture, autoreactive lymphocytes (17-19). Moreover, we have observed that ab-
normalities in the development of TdT+ bone marrow cells and/or thymocytes
precede the onset of autoimmunity in several other mutant mouse models,
including the NZB, NZB/W F, and BSXB models of systemic lupus erythema-
tosis, and the SJL/J and PL/J models of experimental allergic encephalomyelitis
(20 and our unpublished observations). Also, it has been noted (1, 21-24) that
the predisposition to autoimmunity can be passed from these mutant mice, and
from me/meand me"/me" mice, to normal naive recipients by the adoptive transfer
of bone marrow cells. Hence, it is possible that the reported abnormalities in the
development and function of peripheral T and B cells in me/me and me"/me`' mice
may similarly be related to the defective development ofTdT+ cellsand/or other
lymphoid precursor cells. This study is designed to provide such information.
Preliminary experiments in our laboratories, using the traditional i.v. adoptive
transfer assay system to identify prothymocytes (25), failed to identify cells in the
bone marrow of me/me or me"/me" mice that were able to repopulate the thymus
of normal irradiated recipients. Therefore, we have used a novel intrathymic
(i.t.) adoptive transfer system (26), which is independent of cell migration, to
attempt to detect prothymocytes in the bone marrow of these mutant mice. The
results indicate that prothymocytes are indeed present in me/me and me"/me"
mice, but that they are unable to home effectively to the thymus via the blood.
We have also traced the development of B cell precursors in the bone marrow
of me/me and me"/me" mice by detecting the B220 differentiation antigen (27-
30). The results demonstrate a marked depletion of all B-lineage cells in the
bone marrow of me/me and me"/me" mice. In addition, we have studied the
development of TdT+ bone marrow cells in these mutant mice. The results not
only confirm the marked depletion of TdT' cells in me/me mice (11) and extend
this observation to me"/me" mice, but show that a subset of TdT+ cells that
express the B220 antigen is most severely affected. Conversely, the results show
that the appearance of TdT+ thymocytes, which are B220-, is essentially normal
before the premature onset of thymic involution.
Inasmuch as the congeries of lymphoid precursor cell defects observed in this
study arises from a single gene mutation, it seems likely that a common patho-
genetic mechanism is implicated. The results of in vitro studies, presented in a
' Abbreviations used in this paper:
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separate paper,' suggest that this mechanism involves an abnormality in the
stromal microenvironment ofthe bone marrow of me/me and me"/me" mice.
Materials and Methods
Animals.
￿
C3HeB/FeJ me/me, C57BL/6J me/me, C57BL/6J me"/me" mice (Ly-1 .2) and
their heterozygous (+/-) littermates were obtained from the colonies maintained by L.
Shultz at The Jackson Laboratory, Bar Harbor, ME. Age-matched wild-type (+/+)
C3HeB/FeJ mice were obtained from the Animal Resource Colonies of The Jackson
Laboratory. C57BL/6 wild-type (+/+) mice (Ly-1 .2) were obtained from the Mammalian
Genetics and Animal Production Section of the National Cancer Institute, Frederick, MD.
Congenic C57BL/6 Ly-1 .1 mice were obtained from Dr. Edward Boyse, Memorial Sloan-
Kettering Cancer Center, NY.
Adoptive Transfer Assays for Prothymocytes.
￿
Details of the i.v. and i.t. assay systems for
prothymocytes in mice have been described previously (26). Briefly, irradiated recipients
(600 rad) were injected i.v. via the tall vein or directly i.t. with bone marrow cells from
congenic Ly-l-disparate donors, as reported in the text. In some experiments, C57BL/6
Ly-1 .1 bone marrow cells were incubated at 4'C for 30 min with a 1 :5 dilution of serum
prepared from freshly clotted mouse blood (10 pl per 106 cells), and washed once in excess
RPMI before i.v. or i.t. transfer. At various times after reconstitution, the recipients were
killed and the relative and absolute numbers of donor- and host-origin thymocytes were
quantified by immunofluorescence analysis for Ly-1 .1 and Ly-1 .2 alloantigens on the
FACS (FACS IV; Becton Dickinson Immunocytometry Systems, Sunnyvale, CA).
Antisera. mAb against the Ly-1 .1 and Ly-1 .2 mouse pan-T cell alloantigens were
obtained from New England Nuclear (Boston, MA). An affinity-purified IgG fraction of
rabbit anti-TdT, prepared by Dr. F. J. Bollum (Uniformed Services University of the
Health Sciences, Bethesda, MD) (31, 32), was used in these studies. Tissue culture
supernatant from the 14.8 hybridoma cell line, obtained from the American Type Culture
Collection (Rockville, MD), was used to label cells for the early B lineage cell surface
antigen, B220 (27, 28).
Immuno_fluorescence.
￿
Single-cell suspensions ofbone marrowand thymus were prepared
in Hepes-buffered RPMI 1640 tissue culture medium (26). Cell viability was determined
by exclusion of 0 .1 % trypan blue.
Donor- and host-origin thymocytes were detected by incubating aliquots of thymocytes
in suspension with anti-Ly-1 .1 or -Ly-1 .2 antibodies and developing for indirect immu-
nofluorescence with FITC-conjugated goat anti-mouse IgG (heavy and light chain-
specific) (Cappel Laboratories, Cochranville, PA) (26). ?50 x 10' nucleated cells from
each cell suspension were analyzed on the FACS.
In some experiments, the percentage of donor-origin thymocytes that were TdT+ was
determined by fluorescence microscopy on cells doubly labeled for Ly-1 .2 and TdT, as
described previously (26).
The percentages of pre-B (cytoplasmic Ig [cIg]-positive, surface Ig [sIg]-negative) and
B (sIg+) cells were determined by reacting the bone marrow cellsin suspensionwith FITC-
conjugated goat anti-mouse IgG (Cappel Laboratories). Cytocentrifuge-prepared smears
of labeled cells were then fixed in cold 95% ethanol/5% acetic acid. Smears were washed
three times in excess PBS (pH 7.2) and developed for cytoplasmic IgM by incubation with
a tetrarhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse k chain-specific
antibody (affinity purified) (Southern Biotechnology, Inc., Birmingham, AL). Plasma cells
were excluded from analysis on the basis oftheir distinctive morphologyand their pattern
of intense cytoplasmic immunofluorescence.
The percentage of B220+ cellswas determined by sequentially incubating bone marrow
cell suspensions with the 14.8 mAb and with TRITC-conjugated goat anti-rat IgG (Cappel
2 Medlock, E. S., I. Goldschneider, D. L. Greiner, and L. Shultz. Defective lymphopoiesis in the
bone marrow of motheaten (me/me) and viable motheaten (me"/me") mutant mice. II. Description of
a microenvironment defect that inhibits the generation of terminal deoxynucleotidyl transferase-
positive bone marrow cells in vitro. Manuscript submitted for publication.1132
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Laboratories) that had been passed through a normal mouse serum Sepharose 4 B affinity
column to remove crossreacting antibodies (25, 26). For TdT staining, cytocentrifuge-
prepared smears of unlabeled or 14.8-labeled bone marrow and unlabeled thymocyte cell
suspensions were fixed in cold absolute methanol, air dried, and incubated sequentially
with 10 /iel (30 jug) of rabbit anti-TdT followed by FITC-conjugated goat anti-rabbit IgG
(Cappel Laboratories) (26). Singly and doubly labeled cells were counted using a Zeiss
universal fluorescence microscope equipped with narrow band filters for rhodamine and
fluorescein . Pre-B cells (cytoplasmic red) were distinguished from B cells (surface green);
and TdT+ cells (intranuclear green) were classified as 14.8+ (surface red) or 14.8-.
Determination of TdT Enzymatic Activity.
￿
The amount of TdT enzymatic activity in
thymocytes was determined on a lysate obtained by a three-fold sequential freeze-thaw
cycle of packed cells in a 250 mM solution of potassium phosphate. Cell debris was
removed from the lysate by centrifugation at 132,000 g, and aliquots were incubated with
a reaction mixture containing 0.2 M cacodylate buffer (pH 7.5), 0 .01 mM d(pA)5o, 0.1
BSA, 8 mM MgCl2, 1 .0 mM 2-ME, and 1 .0 mM [sH]dGTP (64.3 cpm/pM) for various
times at 36°C. Aliquots were applied to glass fiber squares and collected in cold 5% TCA.
Filters were washed twice in 1 N HCl, rinsed twice in 95% ethanol, and air dried. The
amount of radioactivity in the precipitate was determined by liquid scintillation counting.
The amount of enzymatic activity contained in lysates of thymocytes was calculated from
radioactivity incorporated (31). 1 U of enzyme activity is 1 nM of dGMP incorporated in
60 min .
Results
Prothymocytes.
￿
The thymocyte-regenerating capacity of bone marrow cells
from me/me and me"/me" mice and their +/- littermates (Ly-1 .2) was determined
14-18 d after i.v. injection into irradiated congenic C57BL/6 Ly-1 .1 (+/+ wild-
type) recipients. Results in Table I show that no donor-origin thymocytes were
detected (<10') in the recipients of 2.5 X 106 me/me or 5 X 106 me"/me" bone
marrow cells; whereas 35.8 X 106 and 8 .7 X 106 donor-origin thymocytes (Ly-
1 .2+) were detected after the i.v. transfer of 2.5 X 106 +/- littermate bone
marrow cells, respectively .
Markedly different results were obtained when bone marrow cells were tested
for prothymocyte activity using the i.t. adoptive transfer system. In this system,
me/me and me"/me" bone marrow cells generated donor-origin thymocytes in
numbers roughly equivalent to these generated by bone marrow cells from their
+/- littermates (Table 1). Thus, the i.t. injection of 0 .15 X 106 me"/me" or +/-
littermate bone marrow cells resulted in the appearance of 23 .2 X 106 and 25 .3
X 106 donor-origin thymocytes, respectively, by day 16; and 0 .15 X 106 me/me
or +/- littermate bone marrow cells generated 14.5 X 106 and 22.3 X 106
donor-origin thymocytes respectively, by day 18 .
To confirm that the prothymocyte activity of me"/me" and +/- littermate bone
marrow cells did not differ, the dose-response relationship of thymocyte regen-
eration was determined in the i.t. adoptive transfer system . As seen in Fig. 1, the
percentage and number of donor-origin thymocytes generated at day 16 were
directly proportional to the number of me"/me" and +/- littermate bone marrow
cells that were transferred over the dose range of 0.05-0.15 X 106 cells. No
differences were observed in the absolute or relative numbers of donor-origin
thymocytes that were generated by the me"/me" and +/- littermate mice at any
given cell dose. Neither were there any differences in the proportion of donor-
origin thymocytes that were TdT+ in recipients of me"/me" (81 .8%) and +/-4-6-wk-old congenic C57BL/6 (Ly-1.1) mice were irradiated with 600 radand injected within 2-
6hwith 4-5-wk-old C57BL/6J melme, me"/me", or +/- littermate bone marrow cellsi.t. or i.v.
* Each point represents analysis on the FACS of ?50,000 cells from a pool of two to four recipients,
or the mean ± SD of three to four individual recipients.
Determined by multiplying the total number of thymocytes in each recipient by the percentage of
donor-origin (Ly-1.2+) thymocytes.
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NUMBER OF CELLS INJECTED I.T . (x 10-5)
FIGURE 1 .
￿
The generation of donor-origin thymocytes (Ly-1.2) as a function of dose of
C57BL/6J me"/me" ("- --") or +/- littermate (M-- -40) bone marrow cells injected i.t. into
irradiated (600 rad) C57BL/6 Ly-1.1 congenic recipients. (A) Percentage and (B) number of
donor-origin thymocytes 16 d after i.t. injection of graded numbers of bone marrow cells.
Each point represents the mean of three or four individual animals. The best fit lines were
determined by linear regression analysis (r2>0.90 in all cases).
0.15
Genotype
Route of
bone mar-
row cell in-
jection
Number of
bone mar-
row cells in-
jected (x
10-6)
Days after
bone mar-
row cell in-
jection
Donor-origin
Percentage
thymocytes*
Number (x 10-6)
per thymus*
me/me i .v. 2.5 18 <1 .0 <1 .0
i.t. 0.15 18 48.3 ± 15.3 14.5 ± 8.5
+/- littermate i.v. 2.5 IS 55.3 35.8
i.t. 0.15 18 59.9 ± 9.8 22.3 ± 11 .6
me"/me" i .v. 5.0 14 <1 .0 <1 .0
i.v. 2.5 16 <1 .0 <1 .0
i.t. 0.15 16 27.3 ± 8.7 23.2 ± 9.7
+/- littermate i .v. 5.0 14 17.6 ± 7.7 11 .5 ± 6.7
i.v. 2.5 16 9.7±3.9 8.7±4.3
i.t. 0.15 16 33.1 ± 3.8 25.3 ± 12 .71134
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TABLE 11
Prothymocyte Activity ofNormal Bone Marrow Cells after Treatment with
me/me, me'/me, +/- Littermate, or +/+ Wild-type Mouse Serum
4-6-wk-old wild-type C57BL/6 (Ly-1.2)mice were irradiated with 600 rad and
injected i.v. (2.5 X 106) or i.t. (0.1 X 106) with serum-treated bone marrow
cells obtained from 4-wk-old C57BL/6 (Ly-1.1) congenic mice (see Materials
and Methods). Donor-origin thymocytes were quantitated by FACS analysis on
day 20.
* Each value represents the mean ± SD of ?50,000 cells from three to four
individual recipients. No significant differences were observed within any of
the groups (p > 0.2).
Determined by multiplying the total number of thymocytes in each recipient
by the percentage of donor-origin thymocytes.
littermate (79.6%) bone marrow cells. Furthermore, the numbers and propor-
tions of TdT+ and TdT- thymocytes generated in the adoptive recipients after
the i.t. injection of me"/me" and +/- littermate bone marrow cells were compa-
rable to those observed after the i.t. injection of +/+ wild-type bone marrow
cells (26 and our unpublished observations).
To test the possibility that autoantibodies in me/me and me"/me" mice may have
prevented the generation of thymocytes in the Lv.- (but not Lt.-) injected
recipients, C57BL/6 Ly-1 .1 (wild-type) bone marrow cells were incubated with
serum obtained from me/me, me"/me", +/- littermate, or wild-type mice before
their adoptive transfer into irradiated congenic C57BL/6 (Ly-1.2) recipients. As
seen in Table 11, none of the above sera significantly inhibited the generation of
donor-origin thymocytes in either the i.v. or i.t. assay systems.
TdT+ Bone Marrow Cells and Thymocytes.
￿
As determined by immunofluores-
cenceanalysis, the bone marrow of 4-5-wk-old C3HeB/Fej me/me and C57BL/6j
me/me mice was almost completely devoid of TdT+ cells (Table 111). However,
in contrast to an earlier report (11), the relative and absolute numbers of TdT+
thymocytes in two of the four C57BL/6j me/me mice examined were comparable
to thoseobserved in +/- littermates and wild-type C57BL/6 controls. Therefore,
Route of bone
marrow cell in-
jection
Source of serum used
for treatment
Donor-origin
Percentage
thymocytes*
Number (X 10-')
per thymus
i.v. me/me 22.9 ± 14.8 11 .8 ± 7.9
+/- littermate 23.3 ± 15.3 11 .4 ± 8.9
me"/me" 31 .6 ± 11 .7 17.0 ± 11 .6
+/- littermate 28.4 ± 16.5 18.3 ± 13.6
+/+ wild type 37.5 ± 1.3 20.6 ± 8.8
Medium 30.5 ± 6.6 17.9 ± 5.7
i.t. me/me 47.9 ± 14.2 41 .7 ± 20.4
+/- littermate 48.1 ± 17.2 43.7 ± 15.1
me"/me" 33.5 ± 4.2 19.4 ± 9.3
+/- littermate 54.7 ± 7.1 35.0 ± 8.4
+/+ wild type 49.0 ± 14.0 41 .8 t 17.8
Medium 40.0 ± 7.9 25.2 t 1.2TABLE III
Number of TdT+ Cells in Bone Marrow and Thymus ofme/me Mice
GREINER ET AL.
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+' Results represent the means oftwo mice or the mean tSD ofthree to five mice.
Numbers ofTdT* cells in 4-5-wk-old me/meand +/-littermates, corrected for the reported (1) differences in body weight between
me/me and +/- littermates.
11 Not significantly different than +/- littermate controls.
TABLE IV
Number of TdT+ Cells in Bone Marrow and Thymus of me"/me" Mice of Various Ages
TdT' cells'
" Results represent the pooled mean of two to four mice or mean ± SD of three to six mice.
S Numbers of TdT' cells corrected for reported (3) differences in body weight between me"lme° and +/- littermates.
11 Not significantly different than +/- littermate controls.
in order to further trace the development of TdT+ bone marrow cells and
thymocytes in these mutant mice, especially before theonset ofthymic involution,
we studied the ontogeny of these cells in C57BL/6J me"/me" mice, which have a
longer life span than do their me/me counterparts. Like the me/me mice, the
mev/me" mice had greatly reduced numbers and proportions of TdT+ bone
marrowcells at 5 and 6 wk age (Table IV). Furthermore, this deficiency was also
present at 2 wk ofage, even when the bone marrow cellularity was adjusted for
the previously reported (3) decrease (15-25%) in body weight of mev/me" mice
in relation to their +/- littermates. However, the relative and absolute number
of TdT+ thymocytes, when adjusted for the reported differences in body weight
(3), approached normal values in 2- and 3-wk-old mev/me" mice, and then
decreased rapidly with the early onset of thymic involution.
Age (wk) Genotype
Percentage
Bone marrow
Number (X10-") per leg
(femur and tibia) Percentage
Thymus
Number (X 10- 6)
per thymus
2 me'/me' 0.4 0.02 (0.02)= 83.11 95.4 (114:5)1111
+/- littermate 2.0 0.08 80.7 16._.6
3 me"/me" 0.2 ± 0.0 0.03 t0.01 (0.03) 75.1 ± 1 .711 37.1 t 9.6 (44.5)1
+/- littermate 1 .7 t 0.3 0.38 t0.23 74.0 t 1 .5 67.5 t 14.2
4 me"/me" 0.5 t 0.4 0.14 t0.08 (0.18) 64.6 t 7.71 46.7 t24.2 (84.1)
+/- littermate 3.2 f 0.6 1.23 t0.66 76.6 t5.4 130.5 t 16.3
5 me"/me" 0.2 t 0.2 0.02 t 0.02 (0.03) 55.7 t31 .911 9.0 t8.1 (12.6)
+/- littermate 1 .6 ± 0.7 0.34 t 0.14 77.3 t3.5 134.1 t71.9
6 me"/me' 0.1 0.03 (0.04) 38.6 0.4 (0.6)
+/- littermate 1.4 0.51 75.5 110.9
TdT' cells*
Strain Genotype Bone marrow Thymus
Percentage Number (X 10- 6) per Percentage Number (X 10-6)
leg (femur and tibia) per thymus
C3HeB/Fej me/me 0.2 t 0.1 0.02 t 0.02 (0.03 69.8 t 1 . If 6.5 t4.6 (9.1)t
+/- littermate 3.8 t 0.9 0.69 t 0.11 74.9 t 1 .5 137.6 t 10.0
+/+ wild type 1 .8 t 0.4 0.28 t 0.11 77.1 t3.8 129.0 341 .4
C57BL/6J me/me 0.4 0.11 (0.15) 70.8 3.7 (5.2)
me/me <0.1 0.02 (0.03) 75.4 96.2 (134.7)
+/- littermate 2.5 t 1.1 0.27 t 0.08 77.8 t3.4 85.3 t50.0
+/+ wild type 1 .7 t 0.7 0.35 t 0.17 76.9 t 1.6 90.2 f5.21136
Strain
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Thymocytes were obtained from 4-5-wk-old C57BL/6J me/me,
C57BL/6J me"/me", their +/- littermates, and C57BL/6 +/+ wild type
mice. Results represent the means of one to three mice or the mean ±
SD of four to six mice. No significant differences were observed between
groups.
* The amount of TdT enzymatic activity was determined on a lysate of
packed thymocytes (see Materials and Methods). The number of TdT
units per TdT* thymocyte was determined by dividing the total amount
of TdT enzymatic activity per cell by the percentage of TdT+ thymo-
cytes.
TABLE V
TdT Enzymatic Activity ofme/me and me°/me° Thymocytes
Genotype
￿
TdT* cells (%)
TABLE VI
B-lineage Cells in Bone Marrow of me/me and me'/me' Mice
TdT (U) per 108
TdT* thymocytes*
C3HeB/Fej
C57BL/6J
Bone marrow cells from 4-5-wk-old mice were stained with anti-TdT, anti-IgM, anti-IgG and/or anti-B220 (14.8) antibodies (see Materials
and Methods). Results represent the means ± SD of three to four mice.
* Not significantly different from +/- littermate controls.
To confirm the immunofluorescence data, we determined the enzymatic
activity of the TdT in thymocytes from me/me and me"/me" mice . As seen in
Table V, the amount of enzymatic activity per TdT+ thymocyte in me/me and
me`'/me" mice did not differ significantly from that observed in +/- littermates
or in +/+ wild-type, age-matched controls.
B-lineage Bone Marrow Cells.
￿
Bone marrow cells from me/me and me"/me" mice
were examined by immunofluorescence for abnormalities in the development of
early B lineage cells. The percentages and absolute numbers of B cells (slg+),
pre-B cells (clg+, sIg) and B220+ cells (presumptive total B lineage cells) in the
bone marrow of me/me and me"/me" mice were significantly decreased (from
85.0% to 93.0%) with respect to their counterparts in +/- littermates and in
+/+ wild-type controls (Table VI) . In addition, <10% of the TdT+ bone marrow
cells in me/me and me"/me" mice expressed the B220 antigen ; whereas approxi-
Genotype
Total nucleated
(x 10-x) cells
per leg (femur
and tibia) B220'
Distribution
TdT*
B220-
ofB-lineage
B220*
cells (%)
(prB e lcells)
slg' (B cells)
me/me 9.5 ± 4.2 ND ND 1 .3 ± 0.3 0.9 ± 0.4 1.4 ± 0,6
+/- littermate 18.3 ± 1 .4 ND ND 16.6 ± 5.8 6.0 ± 2.1 12.5 ± 1 .9
+/+ wild type 15.7±4.3 51.6±8.9 48.4±10.4 18.7±2.4 6.6±0.9 10.0±2.7
me"/me" 21.8 ± 5.2* 7.1 ± 6.9 92.9 ± 8.6 2.4 ± 0.2 1.0 ± 0.2 1.8 ± 0.5
+/-littermate 21.8±4.3 58.4±8.7 41.6±10.7 20.2±4.9 7.8±0.6 10.0±2.0
+/+ wild type 20.8±2.9 61.4±8.0 38.6±9.2 21.1±5.1 7.6±0.8 11 .2±0.8
me/me
+/- littermate
73.7
81.2
19.3
22.0
me"/me" 67.4 ± 4 .9 24.3 ± 2.2
+/- littermate 76.5 ± 4 .7 21 .2 ± 4.3
+/+ wild type 79.2 ± 1 .5 16.9 ± 0.5GREINER ET AL.
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mately half ofthe TdT+ bone marrow cells in +/- littermate and +/+ wild-type
mice were B220+.
Discussion
We used a newly developed i.t. adoptive transfer system that is independent
of cell migration to show that the bone marrow of me/me and me"/me" mice
contains apparently normal numbers ofprothymocytes. Preliminary experiments,
confirmed here, found that me/me and me"/me" bone marrow cells are unable to
repopulate the thymus of irradiated recipients after i.v. transfer, thereby sug-
gesting that these mutant mice lacked prothymocytes. However, when these
bone marrow cells are injected directly into the thymus, they areable to generate
thymocytes as efficiently as can their counterparts from normal mice. Hence,
although not formally confirmed by cell tracer studies (33, 34), our results
suggest that me/me and me"/me" prothymocytes fail to generate thymocytes in the
i.v. transfer system because they are unable to migrate to or successfully enter
the thymus.
Although developmental abnormalities ofprothymocytes appear to be impor-
tant predisposing factors to autoimmunity in several mutant mouse strains (20-
24), to date, only the prothymocytes in me/me and me"/me" mice appear to have
a thymus homing defect. In contrast, prothymocytes from the New Zealand,
BXSB, and MRL models of systemic lupus erythematosus and the SJL/J murine
model ofexperimental allergic encephalomyelitis readily generate thymocytes in
the i.v. adoptive transfer system (20-24), and their bone marrowcontains normal
or elevated numbers ofTdT+ cells.
The lack ofdetectable prothymocyte activity in me/me and me"/me' mice in the
i.v. assay does not appear to be due to the presence ofautoantibodies, inasmuch
as pretreatment of normal bone marrow cells with serum from these mutant
mice fails to inhibit their thymocyte regenerative capability in either the i.v. or
i.t. assay. In addition, no evidence for inhibitory cell activity has been found in
preliminary mixing experiments ofme"/me" and normal strain bone marrow cells
(K. Komschlies, unpublished observations). Although the nature ofthe observed
migratory defect is unknown, it is clear that the thymus is not at fault in these
mutant mice. Thus, +/- littermate or congenic +/+ wild-type prothymocytes
injected i.v. into me/me and me"/me" mice home efficiently to the thymus (L.
Shultz, unpublished observations). The results of these latter experiments also
speak against a possible role for autoantibodies against prothymocytes.
It is tempting to speculate that the homing defect detected in the i.v. assay for
prothymocytes is a major contributing factor to the early onset of thymic
involution in me/me and me"/me" mice (2, 3). However, if prothymocytes lack the
ability to home effectively to the thymus, what would account for the initial
colonization of the thymus in these mutant mice and the appearance of thymo-
cytes with rearranged Tcell receptor 0 genes (35)? And what would account for
the presence of relatively normal numbers of peripheral Tcells injuvenile mice
(2, 3)? One plausible scenario is that only one wave ofcolonization of the thymus
by prothymocytes occurs during fetal life in me/me and me"/me" mice. Inasmuch
as the generative cycle of intrathymic progenitors is ^-30 d (26, 36), failure to
replace these progenitors by subsequent waves ofprothymocytes would result in1138
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the onset of thymic involution at 2-3 wk of age, which corresponds very closely
to the situation in me/me and me"/me" mice. However, peripheral T cells, being
mostly long-lived, would persist well beyond the onset of thymic involution.
Thus, it has been observed that in normal mice (a) multiple waves of thymus
colonization by prothymocytes occur during fetal development (F. Jotereau,
personal communication) ; (b) prothymocytes seed to the fetal thymus by a
different, partly nonvascular, route than to the postnatal thymus (37, 38); (c) the
thymus is more permeable to the passage of cells in fetal and neonatal life than
in adult life (39, 40); (d) prothymocytes originate primarily in the liver of fetal
mice, and in the bone marrow of postnatal mice (25, 26, 37, 41); (e) thymocytes
in the fetal and neonatal periods have different properties than those that appear
in older animals (42-44); and (f) thymectomy conducted in 3-4-wk-old mice
does not significantly affect the levels of peripheral T cells until several months
thereafter (45). Studies are in progress to determine whether defective homing
is also exhibited by fetal prothymocytes in me/me and me"/me" mice, or only by
prothymocytes that develop after the primary colonization of the thymus has
occurred.
It could, of course, be argued that the explanation for the present results is
that the i.v. and i.t. assays detect different lineages of bone marrow prothymo-
cytes, and that one of these lineages may be missing in me/me and me"/me" mice.
However, no differences between the i.v. and i.t. assays have been found in
experiments in which normal mice were used to create radiation chimeras. In
such chimeras, the ratios of donor-origin TdT+ and TdT- thymocytes and of
peripheral T cell subsets with helper and suppressor antigenic phenotypes ap-
proximated normal values in both assay systems (25, 26). Similarly, in the present
study, prothymocytes from me/me and me"/me" mice generated normal ratios of
TdT+ (presumptive cortical) and TdT- (presumptive medullary) thymocytes in
the i .t. assay.
A more likely explanation is that the i.v. and Lt . assays detect prothymocytes
at different stages of maturation ; the i.v. assay detecting mature (migratory)
prothymocytes only, and the i.t. assay detecting both mature and immature
(nonmigratory) prothymocytes. Given that the prothymocyte activity of me/me
and me"/me' bone marrow, as detected by the i.t . assay, was comparable quanti-
tatively to that of +/- littermate bone marrow, this hypothesis would predict
that almost all of the prothymocytes in these mutant mice belong to the immature
cell subset. Evidence supporting this conclusion is provided by in vitro studies2
of the development of TdT+ bone marrow cells in me/me and me"/me` mice. The
results show that, although bone marrow from these mutant mice is markedly
deficient in TdT+ cells, it can readily generate such cells in vitro when placed on
a feeder layerof stromal cells from +/+ wild-type bone marrow. However, unlike
bone marrow from normal mice, only the B220- subset of TdT+ cells (presump-
tive T lineage, see below) is generated in vitro by me/me and me"/me" bone
marrow cells. These findings therefore suggest that the mutant prothymocytes
undergo a maturational arrest at the stage immediately precedingthe expression
of TdT (i.e., at the "pre-TdT-cell" stage [14]).
In addition to the defective development of prothymocytes, the results of this
study show that there is a marked deficiency of all of the identifiable membersGREINER ET AL.
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of the B lymphocyte series in the bone marrow of me/me and me"/me" mice,
including pre-B cells and their B220', cIg, sIg precursors. Thus it is possible
that the depletion of peripheral B lymphocytes that has been observed in me/me
and me"/me" mice (3-8) may result from the defective development of early B
cell precursors. Alternatively, the deficiency of early B lineage precursors and
peripheral B cells may be due to the rapid exit ofthe former cells from the bone
marrow, followed by the rapid differentiation of the latter cells into plasma cells
(46, 47).
The levels ofpre-B cells that we observed in the bone marrow of 4-5-wk-old
me/me (0.97%) and me"/me" (1 .0%) mice approximate those recently reported by
McCoy et al. (48) for 19-22-d-old me/me mice (2.1%). However, the levels of
pre-B cells that we detected in the age-matched +/- littermates and +/+ wild-
type controls (6.0-7.8%) were substantially higher than those reported by McCoy
et al. (47), and were comparable instead to previously reported values for normal
adult mice (48, 49). Thus, our results indicate that young adult me/me and
me"/me" mice are markedly depleted of early B lineage bone marrow cells,
whereas results of McCoy et al. (47) suggest that 3-wk-old mutant mice are not
significantly depleted ofB cell precursors. These observations are consistent with
previous reports of a marked decrease in the numbers of peripheral B cells in
me/me and me"/me" mice, which first becomes apparent after 3 wk of age. It
appears therefore that the generation of B cells, like that of thymocytes, is
relatively normal in the neonatal period, but is markedly restricted thereafter by
an arrest in the maturation of lymphoid progenitor cells. This conclusion is
further supported by our observation that B220+ bone marrow cells, which
include all of the pre-B cells and their immediate precursors (27, 28), also are
severely depleted in young adult me/me and me"/me" mice . It is important to note
that the B220 antigen is absent from prothymocytes,3 pluripotent hemopoietic
stem cells (27, 28), and myeloid and erythroid progenitor cells (27, 28). It is also
important to note that some peripheral B cells are present in me/me and me"/me"
mice (3-8, 47); and that, in the presence of elevated levels of compensatory B
cell maturation factors (BMF), they may account for the reported polyclonal B
cell hyperactivity and autoantibody production in these animals (5, 9, 10).
As reported previously (11) and confirmed here, marked deficiencies are
apparent in the generation of TdT' bone marrow cells in me/me mice . We now
provide evidence that this deficiency occurs in me"/me" mice as well. Moreover,
we show that TdT+ bone marrow cells can be divided into two roughly equal
subsets on the basis of their differential expression of the B220 antigen, and that
me"/me"miceare most severely depleted ofthe B220+ subset. Thus, thedeficiency
of the B220+ subset of TdT' bone marrow cells in me/me and me"/me" mice
correlates with the deficiency of early B-lineage cells; the ability to generate the
B220- subset of TdT+ cells correlates with the ability to generate prothymo-
cytes.2 In support ofthis notion, we have recently shown2 that all prothymocyte
activity measured by both the i.t. and i.v. adoptive transfer systems is found in
the B220- fraction of normal mouse bone marrow cells; others have shown that
s Greiner, D. L., E. S. Medlock, and 1. Goldschneider. Separation of murine lymphopoietic
precursor cell subsets on the fluorescence-activated cell sorter using the 14.8 monoclonal antibody
to the B220 antigen. Manuscript in preparation.1140
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all B cell precursor activity detected by the in vitro clonable B cell assay is present
in the B220+ fraction of bone marrow cells (27, 28).
It is unlikely that early lymphoid precursor cells in me/me and me"/me" mice
are depleted (or their development is inhibited) by autoantibodies, inasmuch as
we (unpublished observations) and others (11) have been unable to detect
antibodies in the serum of these mice to bone marrow TdT+ cells or to prothy-
mocytes. It is also unlikely that the defective development of lymphoid precursors
in me/me and me"/me" mice is due to stress-induced increases in the levels of
circulating adrenal corticosteroid hormones (50-52), because TdT+ bone mar-
row cells are markedly depleted in 2- and 3-wk-old me"/me" mice, at a time when
the number of steroid-sensitive TdT+ thymocytes (52) is essentially normal.
Finally, it is unlikely that lymphopoiesis occurs at a site other than the bone
marrow in me/me and me"/me" mice. Neither TdT+ cells nor pre-B cells are
present in significant numbers in the spleen (11, 47, and our unpublished
observations), and the onset of thymic involution and depletion of peripheral B
cells in these mutant mice significantly precedes that in the +/- littermate and
+/+ wild-type controls.
While the defective development in me/meand me"/me° mice of prothymocytes,
B cell progenitors, and TdT+ cells appears to be indigenous to the bone marrow
and results from a single gene mutation, it is likely that a common mechanism is
implicated. We believe that the most likely explanation for the observed defects
in the development of lymphopoietic progenitor (or stem) cells in me/me and
me"/me" mice is an abnormality in the microenvironment of the bone marrow.
Thus, in a separate paper,2 we have used a selective culture system for TdT+
cells (53) to demonstrate that stromal cell feeder layers generated by bone
marrow cells from me/me and me"/me" mice not only fail to support the generation
of xenogeneic TdT+ cells in vitro, but prevent feeder layers of stromal cells from
+/- littermate bone marrow from doing so. Furthermore, although me/me and
me"/me" bone marrow cells can generate TdT+ cells when placed onto stromal
cell feeder layers from normal mice, only the B220- subset of TdT+ cells is
effectively generated. These in vitro results appear to correlate with our in vivo
findings, in which the B220+ (presumptive B lineage) subset of TdT+ bone
marrow cells is almost totally depleted in me/me and me"/me" mice, and in which
prothymocytes appear to be developmentally arrested at the pre-TdT+-cell stage
(14) .
Summary
This study identifies defects in the early stages of lymphopoiesis that may
contribute to the abnormalities in the development and/or function ofperipheral
T and B lymphocytes in mice homozygous for the motheaten (melme) and viable
motheaten (me'/me") mutations. The results indicate that in melme and me"/me'
mice (a) prothymocytes in bone marrow are present in essentially normal num-
bers, as determined by intrathymic injection, but apparently lack the ability to
home effectively to the thymus, as determined by intravenous transfer; (b) early
B lineage cells in bone marrow, identified by the B220 antigen, are markedly
depleted, including immature B cells (sIg+), pre-B cells (cIg+, sIg), and pro-B
cells (B220+, cIg, slg); (c) TdT+ bone marrow cells, especially a subset thatWe thank Mrs. Frances Tausche, Ms. Marianne Angelillo, and Mr. Jerome Murphy for
their expert technical assistance, and Mrs. Ruth Conrod for typing the manuscript.
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expresses the B220 B lineage antigen, are markedly depleted by two weeks of
age ; (d) normal numbers of TdT+ thymocytes are present during the first 3 wk
of postnatal life, but rapidly decrease thereafter. The results further indicate
that neither the defective thymus homing capacity of prothymocytes nor the
deficiency of TdT+ bone marrow cells is due to autoantibodies.
The possible relationship of the defective development of lymphoid precursor
cells to the premature onset of thymic involution and to the abnormalities of
peripheral T and B lymphocytes in me/me and me"/me" mice is discussed; as are
the results of in vitro studies (presented in a companion paper), which suggest
that a primary defect in the stromal microenvironment of the bone marrow is
responsible for the abnormal development of the lymphoid precursor cells.
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